Sotera Health (NYSE:SHC – Get Rating) and Mangoceuticals (NASDAQ:MGRX – Get Rating) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation. Earnings and Valuation This table compares Sotera Health and Mangoceuticals’ top-line […]
Sotera Health (NYSE:SHC – Get Rating) and Mangoceuticals (NASDAQ:MGRX – Get Rating) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and profitability. Earnings and Valuation This table compares Sotera Health and Mangoceuticals’ gross […]
Sotera Health (NYSE:SHC – Get Rating) issued an update on its FY 2023 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $0.78-$0.86 for the period, compared to the consensus earnings per share estimate of $0.80. The company issued revenue guidance of $1.05 billion-$1.09 billion, compared to the consensus revenue estimate […]
Sotera Health (NYSE:SHC – Get Rating) had its target price decreased by Barclays from $21.00 to $20.00 in a research note issued to investors on Thursday, The Fly reports. A number of other brokerages have also recently weighed in on SHC. Wolfe Research raised Sotera Health from a peer perform rating to an outperform rating […]
Sotera Health (NYSE:SHC – Get Rating) updated its FY23 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $0.78-0.86 for the period, compared to the consensus estimate of $0.80. The company issued revenue guidance of $1.055-1.090 billion, compared to the consensus revenue estimate of $1.07 billion. Sotera Health also updated its […]